Alexandria Real Estate Equities (ARE) Prepares for Q3 2026 Earnings Amid Soft Leasing Demand
Key Takeaways
- Alexandria Real Estate Equities is scheduled to report its third quarter 2026 results after the market closes on Monday, October 26, 2026, followed by a conference call on Tuesday, October 27.
- Wall Street consensus points to adjusted FFO (Funds From Operations, a key profitability measure for REITs) of about $1.52 per share, down roughly 31.5% from the year-ago quarter.
- Consensus revenue sits near $644 million, implying a year-over-year decline of about 14% as life-science leasing demand remains soft.
- Investors will focus on occupancy, same-store performance, and any update to the company's full-year 2026 FFO guidance range of $6.35 to $6.45 per share.
- For more context on this ticker's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated ARE pages.
- Looking for additional market ideas? Explore Trending AI Robots for AI-driven trading signals.
Earnings Context and Why It Matters
Alexandria Real Estate Equities stands as the largest publicly traded owner, operator, and developer of life-science and technology campuses in the United States, with key concentrations in Greater Boston, San Diego, and the San Francisco Bay Area. Its quarterly results serve as a useful indicator of demand for laboratory and R&D space, a sector that has cooled noticeably after the pandemic-era surge. With shares down more than 45% over the past 52 weeks and the company having already trimmed its full-year guidance in the prior report, this upcoming print will help clarify whether leasing activity and occupancy levels are beginning to stabilize. The results should also shed light on how interest rates and a slower venture-capital environment are affecting a leading life-science landlord. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Earnings Expectations
Analysts expect Alexandria Real Estate Equities to report adjusted FFO of approximately $1.52 per share for the third quarter of 2026, a decline of roughly 31.5% from $2.22 per share in the same period a year earlier. Consensus revenue is projected near $644 million, down about 14% year over year. On a GAAP basis, some estimates point to a modest per-share loss. Key metrics in focus include portfolio occupancy, which analysts estimate near 86%, as well as same-store revenue and same-store NOI, both of which are expected to decline. The company's prior report highlighted full-year 2026 FFO guidance of $6.35 to $6.45 per share, and investors will watch for any revision to that outlook.
Market Reaction and Investor Sentiment
Sentiment heading into the third-quarter report remains cautious. At its second-quarter update, Alexandria reported revenue and adjusted FFO that topped consensus, yet the stock still fell sharply after the company's full-year guidance disappointed investors. That reaction underscores how guidance and forward commentary, rather than backward-looking results, are driving the stock. Persistent concerns around life-science oversupply, elevated vacancies in key markets, and higher borrowing costs have kept pressure on the shares, which have lagged both the broader market and the real estate sector over the past year. As a result, the market is likely to react most strongly to occupancy trends, leasing volume, and any changes to the company's outlook. From what I see, checking comparable names via Tickeron’s AI Daily Buy/Sell Signals can help put these sector-specific pressures into broader context.
Forward Outlook and Key Factors to Monitor
Following the report, investors should watch several themes that will shape Alexandria Real Estate Equities' trajectory. First is occupancy and leasing momentum. The life-science sector is working through a wave of new supply, and signs that vacancy rates are stabilizing would be an important positive signal, while further softening could weigh on results.
Second, funding conditions for the company's tenant base remain a key variable. Many life-science tenants depend on venture capital and public equity financing to fund their growth, and a slower fundraising environment can translate into weaker leasing demand and lower rents.
Third, attention will remain on the balance sheet and capital deployment. Higher interest rates have raised financing costs across the REIT industry, and investors will be looking for clarity on development pipelines, dispositions, and any deleveraging plans.
Finally, the company's full-year guidance will be a focal point. Whether management reaffirms, narrows, or adjusts its 2026 FFO range will provide a clearer read on near-term earnings visibility and could set the tone for the stock into year-end.
Exploring AI Tools for REIT Analysis
In my own research process, I find Tickeron’s AI Screener particularly useful for filtering REITs and life-science names based on technical patterns, fundamentals, and performance metrics. It allows quick scans across customizable criteria like industry, volatility, and AI signals, helping surface relevant setups ahead of events such as earnings. This kind of tool can streamline the comparison process when evaluating names like ARE against peers.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ARE sees its 50-day moving average cross bearishly below its 200-day moving average
The 50-day moving average for ARE moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 25, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARE as a result. In 46 of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
ARE moved below its 50-day moving average on September 24, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ARE crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
The Aroon Indicator for ARE entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ARE's RSI Indicator exited the oversold zone, 17 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 52%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 32 of 56 cases where ARE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for ARE just turned positive on October 23, 2026. Looking at past instances where ARE's MACD turned positive, the stock continued to rise in 22 of 34 cases over the following month. The odds of a continued upward trend are 65%.
ARE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.538) is normal, around the industry mean (0.873). P/E Ratio (102.987) is within average values for comparable stocks, (201.021). Projected Growth (PEG Ratio) (0.280) is also within normal values, averaging (0.666). Dividend Yield (0.072) settles around the average of (0.163) among similar stocks. ARE's P/S Ratio (7.435) is very high in comparison to the industry average of (2.856).
The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. ARE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a real estate investment trust
Industry REITOffice
Advertisement